Trinity Biotech TRIB 深 沪
已收盘 08-21 16:00:00 美东时间
10.60
+0.050
+0.47%
华盛通- 最 高11.245
- 今 开10.95
- 成交量 8110股
- 最 低 10.285
- 昨 收 10.55
- 总市值 715.53万
- 52周最高 52.50
- 市盈率 静 --
- 换手率 1.20%
- 52周最低 7.94
- 委 比 82.94%
- 总股本 67.50万
- 历史最高 4176.00
- 量 比 0.17
- 振 幅 9.10%
- 历史最低 8.46
- 每 手 1
- 风险率 8.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Trinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and Regains Compliance with Nasdaq Minimum Bid Price Requirement
Trinity Biotech received $7 million from Perceptive Advisors to support growth initiatives, including CGM+ and Trinovium. The company regained compliance with Nasdaq's minimum bid price requirement. The investment includes $2.5 million in new debt and $4.5 million in capitalized interest. Trinity Biotech is advancing its strategic priorities, including diagnostics, metabolic health, and AI data center cooling solutions. The company also announced...
08-14 13:32
Trinity Biotech Announces ADS Ratio Change From One ADS Representing 20 Ordinary Shares To One ADS Representing 600 Ordinary Shares
For Trinity Biotech Plc ADS holders, the change in the ADS ratio will have the same effect as a one for-thirty reverse ADS split and is intended to i) enable the Company to regain compliance with the $1.00 Nasdaq minimum bid price requirement, and ii) facilitate investment from a broader pool of pot...
07-22 19:19
Trinity Biotech Terminates Standby Equity Purchase Agreement With YA II
Trinity Biotech plc (NASDAQ:TRIB), a commercial stage biotechnology company focused on human diagnostics and the development of innovative solutions addressing unmet clinical and industrial needs, today announced that it has formally provided notice of termination to YA II PN, LTD., an affiliate of ...
06-30 03:17
Trinity Biotech的人工智能转型掩盖技术故障
核心事件：三一生物科技（TRIB）宣布成立全资子公司Trinovium切入AI数据中心液冷赛道，叠加极端交易量异动，出现剧烈技术破位，成为市场焦点。 关键交易与...
06-24 19:18
Trinity Biotech交易量激增 股价大涨32%
三一生物科技（TRIB）盘中涨幅超32%，报价0.77美元，突破此前0.75美元的20日及60日高点，但本次上涨无对应基本面催化事件，属于脱离0.56-0.7...
06-23 20:17
Trinity Biotech Q1 EPS $(0.23) Up From $(0.48) YoY, Sales $10.846M Up From $7.570M YoY
Trinity Biotech (NASDAQ:TRIB) reported quarterly losses of $(0.23) per share. This is a 52.08 percent increase over losses of $(0.48) per share from the same period last year. The company reported $10.846 million in sales this quarter. This is a 43.28 percent increase over sales of $7.570 million th...
06-16 22:02
Trinity Biotech Secures Additional Purchase Orders For 2M+ TrinScreen HIV Tests, For Q3 2026 Delivery
– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets – Company publishes Q1 2026 financial results with revenue in line with prior guidance & substantial year-on-year gross margin percentage improvements DUBLIN, June 16, 2...
06-16 21:12
Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Kyverna Therapeutics Inc (NASDAQ: KYTX) shares rose 25.8% in pre-market trading after positive trial results for miv-cel. Other gainers include HCAI, ELPW, and ALP.
04-22 17:31
Trinity Biotech Announces Successful Clinical Test Results For New Prostate Cancer Test AI-Incorporated Algorithm
The performance of the upgraded test was evaluated in a comprehensive clinical study involving approximately 750 patient samples, representing a substantially larger and more ethnically diverse cohort than EpiCapture's
03-23 21:26
Trinity Biotech Expects Q4 Revenue Range ~$11.5M - $12.5M
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced an update on its trading
03-10 19:51
